Evidence map›Paper›PMID 12525655›Full record

ArticleJournal of virology2003

The promyelocytic leukemia protein does not mediate foamy virus latency in vitro.

Christopher D Meiering, Maxine L Linial

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Christopher D MeieringDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Maxine L Linial
Fred Hutch Cancer Center · US

Funding

Interdisciplinary Tranining in Cancer ResearchT32CA080416 · NCI · UNIVERSITY OF WASHINGTON · PI STODDARD, BARRY L. · 1998 to 2023
$9.7M
FOAMY VIRUS INFECTION IN VITRO AND IN VIVOR01CA081297 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LINIAL, MAXINE L · 2001 to 2005
$1.5M
NCI NIH HHS CA81297NCI NIH HHS R01 CA081297NCI NIH HHS T32 CA080416NCI NIH HHS T32 CA80416
6 · The paper itself

Abstract

Spumaviruses, commonly called foamy viruses, are complex retroviruses that establish life-long persistent infections in the absence of accompanying pathology. Depending upon cell type, infection of cells in tissue culture cells can result in either lytic replication, persistence, or latency. The cellular factors that mediate foamy virus (FV) latency are poorly understood. In this study we show that the only known inhibitor of FV replication, the promyelocytic leukemia protein (PML), which binds the FV transactivator (Tas), does not play an important role in FV latency in vitro. We found no significant differences in PML levels in cells that supported lytic replication compared to those that were latently infected. Furthermore, endogenous PML levels did not change following exposure to phorbol myristate acetate (PMA), which induces FV replication. We demonstrated that FV replication proceeded in the presence of substantial levels of PML, both in fully permissive cells and during reactivation of latent FV. Endogenous PML did not efficiently colocalize with Tas, even after upregulation by alpha interferon (IFN-alpha) treatment. IFN-alpha did, however, partially suppress the reactivation of latent FV by PMA. Finally, depletion of endogenous PML by small interfering RNA did not promote activation of FV in cells that responded to PMA treatment. Taken together, these data indicate that endogenous PML does not play an important role in mediating FV latency.

Indexed as

Nuclear ProteinsBinding SitesCell LineDNA-Binding ProteinsHumansInterferon-alphaNeoplasm ProteinsPromyelocytic Leukemia ProteinRetroviridae ProteinsRNA InterferenceSpumavirusTrans-ActivatorsTranscription FactorsTumor Suppressor ProteinsVirus ActivationVirus Latencybel1 protein, Human foamy virusbet protein, human foamy virusDNA-Binding ProteinsInterferon-alphaNeoplasm ProteinsNuclear ProteinsPML protein, humanPromyelocytic Leukemia ProteinRetroviridae ProteinsTrans-ActivatorsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID12525655
PMCPMC140967
OpenAlexW2171234810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.